<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the isolation of the 5' flanking region of GRAF (GTPase regulator associated with the focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> kinase), previously described as a putative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor gene of <z:hpo ids='HP_0011009'>acute</z:hpo> myelogenous <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and demonstrate its promoter activity in reporter gene assays </plain></SENT>
<SENT sid="1" pm="."><plain>Two putative protein-binding sites are identified of which one was sensitive to CpG methylation </plain></SENT>
<SENT sid="2" pm="."><plain>The suppressed GRAF expression could be restored in <z:mpath ids='MPATH_336'>leukaemia</z:mpath> cell lines by treatment with a demethylating agent and an inhibitor of <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylases </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast to <z:mpath ids='MPATH_458'>normal</z:mpath> tissues, which tested negative for GRAF promoter methylation, 11 of 29 (38%) bone marrow samples from patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> were positive </plain></SENT>
</text></document>